Tactile Systems Technology Inc (NASDAQ:TCMD) was up 3.9% during trading on Thursday . The stock traded as high as $15.41 and last traded at $15.10, with a volume of 90,951 shares changing hands. The stock had previously closed at $14.53.

Several equities research analysts have recently commented on TCMD shares. Canaccord Genuity started coverage on Tactile Systems Technology in a report on Thursday, August 25th. They set a “buy” rating and a $21.00 price objective for the company. Piper Jaffray Cos. started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set an “overweight” rating and a $17.00 price target for the company. BTIG Research started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set a “buy” rating and a $18.00 price target for the company. Finally, William Blair started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set an “outperform” rating for the company.

The company’s market cap is $50.77 million. The stock’s 50 day moving average price is $13.51 and its 200-day moving average price is $13.51.

In other Tactile Systems Technology news, Director Peter H. Soderberg bought 100,000 shares of Tactile Systems Technology stock in a transaction on Tuesday, August 2nd. The stock was acquired at an average price of $10.00 per share, with a total value of $1,000,000.00. Following the acquisition, the director now owns 5,000 shares in the company, valued at $50,000. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Tactile Systems Technology, Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic diseases at home. The Company focuses on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.